TScan Therapeutics
TCRX
TCRX
89 hedge funds and large institutions have $126M invested in TScan Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.32% less ownership
Funds ownership: 85.9% → 84.59% (-1.3%)
39% less capital invested
Capital invested by funds: $208M → $126M (-$82.1M)
Holders
89
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$2.83M | |
| 2 | +$1.56M | |
| 3 | +$1,000K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$443K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$434K |
Top Sellers
| 1 | -$5.06M | |
| 2 | -$4.29M | |
| 3 | -$2.74M | |
| 4 |
Jane Street
New York
|
-$468K |
| 5 |
Walleye Capital
New York
|
-$422K |